Literature DB >> 21989530

Treating overactive bladder in the elderly.

Adrian Wagg1.   

Abstract

The prevalence of the overactive bladder (OAB) symptom complex increases with age. Older people also appear to experience more severe incontinence syndromes, including OAB, than their younger counterparts. Older patients are more likely than younger individuals to ask for medication for bladder problems and to require higher doses of medication. Conventional treatment for OAB with conservative and lifestyle measures in combination with antimuscarinic pharmacotherapy is effective in older people. Although there is a theoretical potential for cognitive impairment with antimuscarinic agents, the newer antimuscarinics are cognitively safe in cognitively intact older people.

Entities:  

Year:  2011        PMID: 21989530      PMCID: PMC3193391          DOI: 10.5489/cuaj.11188

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  20 in total

1.  Age-associated changes in detrusor sensory function in women with lower urinary tract symptoms.

Authors:  D M Collas; J G Malone-Lee
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

2.  Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.

Authors:  Adrian Wagg; Jean-Jacque Wyndaele; Paul Sieber
Journal:  Am J Geriatr Pharmacother       Date:  2006-03

Review 3.  Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder.

Authors:  A Wagg; C Verdejo; U Molander
Journal:  Int J Clin Pract       Date:  2010-06-07       Impact factor: 2.503

4.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

5.  Combined behavioral and drug therapy for urge incontinence in older women.

Authors:  K L Burgio; J L Locher; P S Goode
Journal:  J Am Geriatr Soc       Date:  2000-04       Impact factor: 5.562

Review 6.  Overactive bladder syndrome in older people.

Authors:  Adrian S Wagg; Linda Cardozo; Christopher Chapple; Dirk De Ridder; Con Kelleher; Michael Kirby; Ian Milsom; Mark Vierhout
Journal:  BJU Int       Date:  2007-03       Impact factor: 5.588

7.  Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.

Authors:  D Staskin; G Kay; C Tannenbaum; H B Goldman; K Bhashi; J Ling; M G Oefelein
Journal:  Int J Clin Pract       Date:  2010-06-17       Impact factor: 2.503

8.  Brain activity during bladder filling is related to white matter structural changes in older women with urinary incontinence.

Authors:  Stasa D Tadic; Derek Griffiths; Andrew Murrin; Werner Schaefer; Howard J Aizenstein; Neil M Resnick
Journal:  Neuroimage       Date:  2010-03-17       Impact factor: 6.556

9.  Assessment of cognitive function of the elderly population: effects of darifenacin.

Authors:  Richard B Lipton; Ken Kolodner; Keith Wesnes
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

10.  Darifenacin treatment of patients >or= 65 years with overactive bladder: results of a randomized, controlled, 12-week trial.

Authors:  C Chapple; C DuBeau; U Ebinger; L Rekeda; A Viegas
Journal:  Curr Med Res Opin       Date:  2007-10       Impact factor: 2.580

View more
  10 in total

1.  CUA guideline on adult overactive bladder.

Authors:  Jacques Corcos; Mikolaj Przydacz; Lysanne Campeau; Gary Gray; Duane Hickling; Christiane Honeine; Sidney B Radomski; Lynn Stothers; Adrian Wagg; Frcp Lond
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

2.  How Beliefs About Bladder Dysfunction Among Health-Care Professionals Influence Clinical Practice Development: Perspectives of Allied Health Professionals, Nurses, and Managers.

Authors:  Catherine Browne; Maria Kehoe; Nancy Salmon
Journal:  Int J MS Care       Date:  2017 Jul-Aug

Review 3.  Mirabegron: a Beta-3 agonist for overactive bladder.

Authors:  Rebecca Bragg; Danielle Hebel; Scott Martin Vouri; Jamie M Pitlick
Journal:  Consult Pharm       Date:  2014-12

4.  Knowledge and understanding of urinary incontinence: survey of family practitioners in northern Alberta.

Authors:  Katherina Nguyen; Kathleen F Hunter; Adrian Wagg
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

5.  Caffeine as a Probable Factor for Increased Risk of OAB Development in Elderly People.

Authors:  Kirill V Kosilov; Sergay A Loparev; Marina A Ivanovskaya; Liliya V Kosilova
Journal:  Curr Urol       Date:  2016-09-20

Review 6.  Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.

Authors:  Adrian Wagg; Matthias Oelke; Javier C Angulo; David Scholfield; Daniel Arumi
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 7.  The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.

Authors:  Karl-Erik Andersson; Nurul Choudhury; Jean-Nicolas Cornu; Moses Huang; Cees Korstanje; Emad Siddiqui; Philip Van Kerrebroeck
Journal:  Ther Adv Urol       Date:  2018-07-06

Review 8.  Important drug–drug interactions for treatments that target overactive bladder syndrome.

Authors:  Sushma Srikrishna; Dudley Robinson; Linda Cardozo
Journal:  Int Urogynecol J       Date:  2014-06       Impact factor: 2.894

9.  Use of onabotulinumtoxinA for overactive bladder with concomitant warfarin.

Authors:  Golden L Peters; Scott Martin Vouri
Journal:  Consult Pharm       Date:  2014-07

Review 10.  Treatment of bladder dysfunction with solifenacin: is there a risk of dementia or cognitive impairment?

Authors:  L P Dantas; A R C C Forte; B C Lima; C N S Sousa; E C Vasconcelos; P H C Lessa; R F Vieira; M C A Patrocínio; S M M Vasconcelos
Journal:  Braz J Med Biol Res       Date:  2022-01-25       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.